Condition
Primary Malignant Brain Tumors
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed2
Withdrawn1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05622409RecruitingPrimary
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
NCT04171895CompletedPrimary
Communication Training for Caregivers In Advanced Care Planning
NCT02058745Not ApplicableCompletedPrimary
SmartCare: Innovations in Caregiving Interventions
NCT01445691Phase 2Withdrawn
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
Showing all 4 trials